HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Warren Hurlburt Selected Research

BMS 754807

2/2015IRS2 copy number gain, KRAS and BRAF mutation status as predictive biomarkers for response to the IGF-1R/IR inhibitor BMS-754807 in colorectal cancer cell lines.
9/2010Differential mechanisms of acquired resistance to insulin-like growth factor-i receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model.
12/2009BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Warren Hurlburt Research Topics

Disease

4Neoplasms (Cancer)
09/2010 - 05/2005
3Rhabdomyosarcoma
09/2010 - 01/2009
2Sarcoma (Soft Tissue Sarcoma)
09/2010 - 01/2009
2Neuroblastoma
12/2009 - 01/2009
1Colorectal Neoplasms (Colorectal Cancer)
02/2015
1Resistance To Insulin-Like Growth Factor I
09/2010
1Leukemia
12/2009
1Liposarcoma
12/2009
1Multiple Myeloma
12/2009
1Ewing Sarcoma (Sarcoma, Ewing)
01/2009
1Adenocarcinoma
05/2005
1Carcinogenesis
05/2005

Drug/Important Bio-Agent (IBA)

3BMS 754807IBA
02/2015 - 12/2009
3IGF Type 1 Receptor (IGF 1 Receptor)IBA
09/2010 - 05/2005
2Biomarkers (Surrogate Marker)IBA
02/2015 - 01/2009
2Phosphotransferases (Kinase)IBA
09/2010 - 05/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2010
1AntibodiesIBA
09/2010
1Insulin ReceptorIBA
09/2010
14- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA
12/2009
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2009
1Caspase 3 (Caspase-3)IBA
12/2009
1BMS 536924IBA
01/2009
1Insulin-Like Growth Factor I (IGF-1)IBA
05/2005
1AS 8IBA
05/2005

Therapy/Procedure

2Therapeutics
09/2010 - 01/2009